Did GLP-1 drugs kill keto? The new dietary guidelines say not so fast

Photo of author

| Published:

GLP-1 drugs are now a fixture of American health culture: 1 in 8 U.S. adults is taking a medication like Ozempic or Wegovy, and the weight-loss conversation now revolves almost entirely around pharmaceuticals. Keto, once the dominant name in carb restriction, looks like it belongs to a different era. Still, the eating behavior underneath the keto label, cut refined carbs, prioritize protein, manage blood sugar, hasn’t gone anywhere; it changed names, found a new partner and picked up a federal endorsement along the way.

Three blue medical injection pens are shown, one with the cap off revealing the needle and dosage window labeled "1 mg.
Photo credit: Depositphotos.

The keto label and low-carb eating are not the same thing, and they haven’t been moving in the same direction. As GLP-1 medications became mainstream, brands quietly dropped the word from packaging while the underlying behavior kept growing. Federal nutrition policy caught up earlier this year, formally acknowledging for the first time that lower-carbohydrate diets may benefit people managing certain chronic diseases.

Keto’s numbers tell half the story

By the middle of last year, keto’s cultural footprint had contracted sharply. Restaurant menus were quietly pulling the label, social conversation had moved on and brands were reformulating without it. The explanation isn’t hard to find. Keto always demanded a great deal: tracking macros to the gram, eliminating entire food groups, pushing through weeks of early fatigue and discomfort that practitioners call the keto flu.

Consumer appetite for that level of restriction had already faded before GLP-1 medications went mainstream. Brands noticed. “Keto” started coming off the packaging, and “High-protein,” “low-sugar” and “gut-friendly” went on in its place. The word was in retreat, but the eating pattern behind it was not.

The pyramid flipped while keto was fading

The retreat of the keto brand masked what was happening in federal nutrition policy at the same time. The 2025-2030 Dietary Guidelines for Americans, released earlier this year, acknowledged for the first time that people managing certain chronic diseases may experience improved health outcomes when following a lower-carbohydrate diet.

The guidelines also inverted the food pyramid, placing protein, healthy fats and whole foods at the foundation while calling for a dramatic reduction in refined carbohydrates and processed foods. That is not the policy framework of a government that considers cutting carbs a fringe idea.

The need is not abstract. More than 70% of American adults are overweight or obese, and nearly 1 in 3 adolescents between 12 and 17 has prediabetes. That is the population for whom federal guidelines now formally recognize a lower-carbohydrate approach as a viable clinical tool.

GLP-1 and low-carb: An unlikely pairing

GLP-1 drugs did not kill low-carb eating, and if anything, they are making it easier to maintain. The medications suppress appetite by quieting the hunger signals that derail most dietary changes; a higher-protein, lower-carb pattern addresses what happens once that appetite suppression takes hold and weight begins to drop.

The diabetes medication reduces the biological resistance to weight loss. Protein-forward, lower-carb eating preserves the lean muscle mass that rapid weight loss tends to erode. Food brands developing products for GLP-1 users naturally land in low-carb territory: smaller portions, higher protein, fewer refined carbohydrates. The two approaches are converging in clinical practice and on supermarket shelves.

The rebrand nobody planned

The macros haven’t changed much, but the name has. High-protein, lower-carb eating is the dominant nutritional framework of 2026, encompassing most of what strict keto practitioners were doing, minus the rigidity and the hashtag. The protein snacks market reflects that change: it is projected to grow from $5.27 billion to $5.86 billion this year and reach $8.87 billion by 2030, according to a recent market analysis. The appetite for low-carb-compatible foods, measured in dollars, has not gone anywhere. It has traded a name that felt extreme for language that feels sustainable.

What comes next

The era of rigid, labeled diets appears to be giving way to something more flexible. Keto as a cultural identity will likely continue to fade. But the core principles underneath keto are now federal policy: cut refined carbs, prioritize protein, manage blood sugar and choose whole foods over processed ones. Federal nutrition guidance and pharmaceutical medicine have landed, for the moment, on the same side of the argument. The diet that everyone declared dead turned out to be the one the government was quietly making a case for all along.

Jennifer Allen is a retired professional chef and long-time writer. Her work appears in dozens of publications, including MSN, Yahoo, The Washington Post and The Seattle Times. These days, she’s busy in the kitchen developing recipes and traveling the world, and you can find all her best creations at Cook What You Love.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.